Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 and sildenafil pharmacokinetic interaction study in mild to moderate hypertension
2012-001632-64Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sacubitril + valsartan and sildenafil in hypertension (HTN), sponsored by Novartis. Primary endpoint: Pharmacokinetics of LCZ696: AUCtau. Started Jul 2012; status: completed.
02
Drugs
sacubitril + valsartansildenafil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2012-001632-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001632-64.